Novartis says Leqvio launch will feature a ‘modest initial ramp,’ but blockbuster potential awaits
Novartis says Leqvio launch will feature a ‘modest initial ramp,’ [...]
GlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing
GlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing [...]
Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone
Novartis’ Sandoz reportedly the target of $25B buyout bid from [...]
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig [...]
Two Biogen board members depart as company struggles to get Aduhelm off the ground
Two Biogen board members depart as company struggles to get [...]
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea
Roche, with an FDA nod for Vabysmo in hand, looks [...]
FDA issues 3 observations to Granules India site in US after pre-approval inspection
FDA issues 3 observations to Granules India site in US [...]
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate [...]
Unable to ‘align’ with FDA, Regeneron, Sanofi pull application for Libtayo in cervical cancer days before decision date
Unable to ‘align’ with FDA, Regeneron, Sanofi pull application for [...]
Fierce Pharma Asia—Samsung Biologics’ mRNA ambition, GSK COVID-19 vaccine supply; Fujifilm’s plant buy
Fierce Pharma Asia—Samsung Biologics’ mRNA ambition, GSK COVID-19 vaccine supply; [...]